Marché européen des dispositifs de traitement du diabète – Tendances et prévisions du secteur jusqu’en 2030

Analyse et taille du marché des dispositifs de traitement du diabète en Europe

Selon la FID, 21 600 enfants viennent s’ajouter chaque année à la population diabétique de type 1. Selon ces chiffres, le diabète représente environ 9 % des dépenses totales de santé en Europe. Diverses initiatives gouvernementales, telles que le programme National Service Framework (NSF) au Royaume-Uni, améliorent les services en établissant des normes nationales pour améliorer la qualité des services et remédier aux variations de soins. Lors du premier forum de ce type, l’Association of British HealthTech Industries (ABHI) a lancé une section sur le diabète, permettant aux entreprises de technologie du diabète de collaborer. Le groupe ABHI s’adresse à toutes les entreprises de technologie de la santé qui s’intéressent aux soins du diabète, des pompes à insuline et CGM aux applications. Ces avantages ont contribué à l’adoption accrue de ces produits sur le marché.

Français Data Bridge Market Research analyse que le marché des dispositifs de soins du diabète, qui s'élève à 6,12 milliards USD en 2022, devrait atteindre 9,67 milliards USD d'ici 2030, à un TCAC de 5,88 % au cours de la période de prévision 2023 à 2030. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée et segmentation du marché européen des dispositifs de traitement du diabète  

Market Definition

Diabetes develops when the pancreas is unable to produce insulin from blood. Untreated diabetes is caused by elevated blood sugar levels. Diabetes drugs are specifically used to treat diabetes. Diabetic treatment aims to increase blood glucose levels. Diabetes care gadgets are used to monitor diabetics' blood glucose levels. A continuous glucose monitor (CGM) is a medical device that tracks and monitors diabetes patients' blood glucose levels throughout the day. This wearable device will benefit diabetics by assisting them in managing their glucose levels.

Europe Diabetes Care Devices Market Dynamics

Drivers

• Rise in obesity

Obesity is one of the leading causes of diabetes in individuals. According to the WHO, approximately 50% of the European population was overweight in 2014, with over 20% of the population obese. Obesity is more common in men. Risk factors, such as the rising prevalence of obesity, are directly linked to the rising prevalence of diabetes, resulting in a high diabetes prevalence. As a result, the diabetes device market is growing.

• Rising awareness about diabetes management

Increasing diabetes patient pool and rising awareness about diabetes management and control are among the factors expected to contribute to this market's growth over the forecast period. According to the International Diabetes Federation Report for 2017, approximately 66.0 million people in Europe have diabetes, with this figure expected to rise to 81.0 million by 2045. The top five diabetic countries in Europe are Germany, the United Kingdom, France, Spain, and Italy.

Opportunities

• Government initiatives and awareness campaigns

Several government initiatives and awareness campaigns are also driving market growth. The UK DESMOND education programme is a structured patient education and management programme for newly diagnosed type 2 diabetes patients. Its goal is to help people identify early health risks. There has also been an increase in government funding for healthcare. Diabetes-related healthcare spending is rapidly increasing, according to the International Diabetes Federation. Diabetes healthcare expenditure in the adult population was USD 207.0 billion in 2017 and is expected to reach 214.0 billion by 2045. Diabetes device demand is expected to be driven by such supportive initiatives and rising awareness over the forecast period.

Restraints/Challenges

• Expensive and Difficulty to Operate Diabetes Care Devices

Diabetes is a chronic illness that necessitates frequent blood glucose testing to maintain normal blood sugar levels. The glucose testing device is costly and can be painful. Furthermore, the results of diabetes care devices are not always accurate. Furthermore, some factors impede market expansion. This includes painful sensor insertions and the difficulty of fitting multiple devices on small bodies. In addition, disruptive alerts lost signals, resulting in data gaps, skin irritation and adhesive issues, and an abundance of information generated by diabetes care devices that was difficult to interpret.

This diabetes care devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the diabetes care devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Diabetes Care Devices Market

The COVID-19 pandemic hampered the growth of the diabetes care devices market. Patients infected with COVID-19 had an increase in blood glucose levels. The stress of infection and the use of steroids for COVID-19 treatment contributed to an increase in blood glucose levels, which increased the number of patients. This undoubtedly created opportunities for market leaders. Many players have launched new advanced diabetes care devices and signed diabetes care device collaborations and agreements because of the rising prevalence of diabetes. However, due to lockdowns and travel restrictions, the market experienced a supply chain disruption, resulting in a scarcity of diabetes care devices; however, this only temporarily impacted the diabetic care devices market.

Recent Developments

• In 2021, NHS (National Health Service) England announced that hybrid closed-loop systems, also known as artificial pancreas, will be available to adults and children on the NHS in England.
• In 2021, Medtronic received a CE mark for its InPen smart insulin pen and Guardian 4 sensor for better diabetes management.
• In 2021, Medtronic launched the Medtronic Extended infusion set in selected European countries, making it the first and only one that can be worn for up to 7 days. This advancement doubles the time an infusion set can be worn, allowing users to safely continue on insulin pump therapy with fewer interruptions and insertions while adding convenience and comfort to their diabetes management routine.

Europe Diabetes Care Devices Market Scope

The diabetes care devices market is segmented on the basis of product type and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Blood Glucose Monitoring Devices
• Testing strips
•  Blood glucose meters
• self-monitoring blood glucose meters
• continuous blood glucose monitoring devices
•  Lancets
• Others
• Insulin Delivery Devices

 Device Type

• Self-monitoring
• Diagnostic

Delivery Type

• Pumps
• Pen
• Syringes
• Injectors
• Cartridges in Reusable pens
• Disposable Pens
• Jet Injectors

 Distribution Channel

• Institutional Sales
• Hospitals
•  Clinics
• Others
• Retail Sales
• Hospital pharmacies
•  Retail pharmacies
• Online pharmacies

Diabetes Care Devices Market Regional Analysis/Insights

The diabetes care devices market is analyzed and market size insights and trends are provided by country, product type and distribution channel as referenced above.

The countries covered in the diabetes care devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the diabetes care devices market because of the presence of well-developed healthcare infrastructure and favourable reimbursement policies in the region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the growing incidence of cancer such as bladder, esophagus, liver, pancreas, and others, high presence of major manufacturers across the U.S. Furthermore, technological advancements and rising foreign investment.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

Le marché des dispositifs de soins du diabète vous fournit également une analyse détaillée du marché pour chaque pays, la croissance des dépenses de santé pour les équipements en capital, la base installée de différents types de produits pour le marché des dispositifs de soins du diabète, l'impact de la technologie à l'aide de courbes de vie et les changements dans les scénarios réglementaires des soins de santé et leur impact sur le marché des dispositifs de soins du diabète. Les données sont disponibles pour la période historique 2011-2021.

Analyse du paysage concurrentiel et des parts de marché des dispositifs de traitement du diabète

Le paysage concurrentiel du marché des dispositifs de soins du diabète fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché des dispositifs de soins du diabète.

Certains des principaux acteurs opérant sur le marché des dispositifs de soins du diabète sont :

• Abbott (États-Unis)
• PHC Holdings Corporation (Japon)
• WellDoc, Inc (Inde)
• Sanofi (France)
• Dexcom, Inc (États-Unis)
• DarioHealth Corp. (États-Unis)
• Medtronic (Irlande)
• B. Braun SE (Allemagne)
• F. Hoffmann-La Roche SA (Suisse)
• Insulet Corporation (États-Unis)
• Ascensia Diabetes Care Holdings AG (Suisse)
• Tidepool (États-Unis)
• Medtronic (Irlande)
• Tandem Diabetes Care (États-Unis)
• LifeScan (États-Unis)
• AgaMatrix (États-Unis)
• Glooko Inc. (États-Unis)
• DarioHealth (Israël)

SKU-1863